Switching to anastrozole plus goserelin versus continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: Preliminary results from a randomized trial | |
Jian-wei, L.; Guangyu, L.; Yajie, J.; Xia, Y.; Zhimin, S.; Da, P.; Zefei, J.; Dedian, C.; Bin, Z.; Binghe, X. | |
2015 | |
会议名称 | EUROPEAN JOURNAL OF CANCER |
会议日期 | 2015-09-01 |
页码 | S315-S315 |
收录类别 | CPCI-S |
URL标识 | 查看原文 |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6386306 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Jian-wei, L.,Guangyu, L.,Yajie, J.,et al. Switching to anastrozole plus goserelin versus continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: Preliminary results from a randomized trial[C]. 见:EUROPEAN JOURNAL OF CANCER. 2015-09-01. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论